EmployblEmploybl logo
employbl
ImmuneID logo

ImmuneID Funding & Investors

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.

immuneidrx.com

Total Amount Raised: $67,000,000

ImmuneID Funding Rounds

  • Series A

    $50,000,000

    Series A Investors

    Alta Partners
    Longwood Fund
    Tekla Capital Management
    Arch Venture Partners
    Alexandria Venture Investments
    Section 32
    In-Q-Tel
    Xfund
    Redwood Capital Investments

  • Series Unknown

    $17,000,000

    Series Unknown Investors

    Longwood Fund
    Xfund
    In-Q-Tel
    Arch Venture Partners
    Pitango
Funding info provided by Diffbot.